To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis

To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis
KFSH&RC-Riyadh

To Bolster Global Efforts in Combating Antibiotic-Resistant Bacteria KFSH&RC Scientists Discover New Bacteria Species: Riyadhensis

RIYADH, Saudi Arabia, March 25, 2024 (GLOBE NEWSWIRE) — In a ground-breaking development, scientists at King Faisal Specialist Hospital and Research Centre (KFSH&RC) have identified a new species of bacteria, referred to as “Stenotrophomonas Riyadhensis” through the application of whole-genome sequencing (WGS) technology. This discovery signifies a major advancement in understanding how bacteria interact with existing drugs, paving the way for innovative therapeutic strategies. Such efforts are essential in the global fight against antibiotic-resistant bacteria, highlighting KFSH&RC’s advanced research capabilities and its leading role in fostering scientific discoveries and enhancing patient care.

The discovery of “Riyadhensis” reinforces the potential of genomic tests in innovating promising diagnostic and therapeutic methods, as well as deepening the understanding of bacterial resistance mechanisms, particularly in sensitive environments like intensive care units (ICU) and among patients with compromised immune systems. This represents substantial progress in combating antibiotic resistance, developing pharmaceuticals, and preventing the spread of diseases.

This newly identified bacteria was discovered amid an in-depth investigation into a suspected outbreak in the ICU of KFSH&RC in 2019, highlighting challenges previously unrecognized by the global scientific and medical communities in pinpointing and countering new bacterial strains. Initially thought to be a variant of Pseudomonas aeruginosa, a disease-causing bacterium known for its resistance to antibiotics, subsequent WGS analysis revealed it did not share the common characteristics of the Pseudomonas genus. Instead, Riyadhensis was found to belong to the Stenotrophomonas family, with a unique genetic composition and morphological traits, unlike any other scientifically recognized members.

Dr. Ahmad Al Qahtani, Head of the Infectious Disease and Immunity Department at The research center of KFSH&RC stated: “Traditional bacterial identification methods may lead to misidentification, in contrast, WGS analysis offers a precise and targeted approach that ensures accurate identification and provides detailed insights into resistance mechanisms, proving its significance in disease outbreak investigations and patient care improvements.”

Dr. Reem Almaghrabi, Head of Transplant Infectious Diseases at the Organ Transplant Centre of Excellence at KFSH&RC highlighted the discovery’s importance in advocating for continuous monitoring and the use of advanced technologies like WGS in developing faster and more accurate diagnostic methods. Furthermore, this approach lays the groundwork for scientific collaboration at all levels, enhancing global efforts to combat antibiotic resistance.

Understanding the nuances of new bacterial species, particularly their antibiotic resistance, is crucial in modern healthcare and serves as the primary means of combating bacterial infections. As these bacteria continuously evolve their resistance, they pose a significant and ongoing threat to human health.

It is noteworthy that KFSH&RC has been ranked first in the Middle East and Africa, and 20th globally, in the list of the top 250 healthcare institutions worldwide for the second consecutive year, according to the 2024 Brand Finance rankings. Additionally in the same year, it was ranked among the world’s best hospitals by the prestigious Newsweek magazine.

King Faisal Specialist Hospital & Research Centre stands among the global leaders in providing specialized healthcare, driving innovation, and serving as an advanced hub for medical research and education. Through strategic partnerships with prominent local, regional, and international institutions, the hospital is dedicated to advancing medical technologies and elevating the standards of healthcare worldwide.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top Academic Medical Centre in the Middle East and Africa, and among the top 20 globally. Additionally, in 2024, it was recognized as one of the World’s Best Hospitals by Newsweek magazine, and ranked # 1 in KSA.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non-profit, government-owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

CONTACT INFORMATION

For more information, please contact:

Mr. Essam Al-Zahrani, Media Affairs Acting Head, 0555254429

Mr. Abdullah Al-Awn, Senior Media Editor, 0556294232

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c4299c01-0079-498b-8350-bd085d769150

GlobeNewswire Distribution ID 9078638

Dominica reaches monumental agreement with other Caribbean Citizenship by Investment nations

Roseau, March 25, 2024 (GLOBE NEWSWIRE) — The citizenship by investment programme (CBIP) countries within the Organisation of Eastern Caribbean States (OECS) have agreed upon legislation to ensure the integrity of their CBIPs, supported by the government of the Commonwealth of Dominica.

The virtual signing ceremony was held on Wednesday, 20 March, the four OECS countries, Antigua and Barbuda, Dominica, Grenada, and St Kitts and Nevis signed the Memorandum of Understanding (MoU) on 20 March 2024. This landmark pact included setting a minimum CBIP price threshold to US$200,000, elucidating the commitment of Caribbean CBI countries to solidify their commitment and maintain the dialogue with international partners.

The MoU includes outlined agreements among the four CBI countries to accomplish the following:

  • Exchange of best practices and due diligence processes
  • Set a minimum threshold of USD200,000 and this threshold must represent the actual amount of funds received
  • Sharing information on applicants;
  • Enhance transparency by disclosing funds;
  • Conduct independent financial and operational audits;
  • Establish regional authority to set regional  standards;
  • Set common standards for communication and promotion;
  • Regulate agents; and
  • Conduct joint training programmes and capacity-building initiatives for CBI administrations.

Dominica leads on CBIP integrity 

The Commonwealth of Dominica was at the forefront of these changes, with the Prime Minister of Dominica, Honourable Dr Roosevelt Skerrit, announcing that he signed the agreed-upon changes ahead of his Tuesday press conference. Dominica continues to demonstrate receptiveness towards enhancing and maintaining the integrity of the CBIP.

As announced in the press conference, Honourable Dr Skerrit explained that the Caribbean CBI countries will work together to address the European Union’s (EU) questions about CBI and visa-free travel to the Schengen area. Honourable Dr Skerrit explained that CBI countries are continuing the push to strengthen the integrity of the CBIPs.

“As you know there are countries within the OECS who have these programmes, Antigua, Dominica, Grenada, St Lucia, and St Kitts and Nevis…and the concerns have been raised by these [European] countries…and the need for all of us to take certain actions to set aside the concerns which the EU in particular would have had with these programme,” Honourable Dr Skerrit said.

Changes made in line with EU dialogue  

Honourable Dr Skerrit reiterated Dominica’s consistent dialogue with the EU, emphasising the meeting held between the five CBI Caribbean countries and the EU Directorate General of Migration and Home Affairs. This is evident in the EU officials visit to Dominica on 24 January 2024 with the OECS countries to discuss the Caribbean CBIPs.

Honourable Dr Skerrit stated that “Dominica has taken some very comprehensive measures to allay and to set aside the concerns of the European Union and other parties who we engage in on this matter.”

“Further to that, the countries within the OECS who have these programmes, we have met jointly, and we have agreed to take some joint actions, some of which, not limited to but include having the same legislation to deal with the whole (CBI) programmes”.

Standardising CBIPs 

The legislation standardises due diligence, information between CBIPs, and sets minimum price structures to ensure no applicants could apply for citizenship ‘below a particular fixed rate’.

These things, Honourable Dr Skerrit maintained, “will place all of us in a much stronger position in terms of our response to the concerns the EU would have raised.”

Attachment

Secretary of Dominica Citizenship by Investment
Commonwealth of Dominica
001 (767) 266 3919
info@cbiu.gov.dm

GlobeNewswire Distribution ID 9078632

Cellebrite Hires Marketing Veteran David Gee as Chief Marketing Officer, Ushering in Next Phase of Growth, Scale and Market Leadership

Appointment Builds on the Momentum Behind Cellebrite’s Preeminent Case-to-Closure Platform and Market-Leading Investigative Solutions to Accelerate Justice

David Gee, Cellebrite Chief Marketing Officer

David Gee was appointed Chief Marketing Officer at Cellebrite.

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 25, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd (Nasdaq: CLBT), a global leader in Digital Investigative solutions for the public and private sectors, today announced the appointment of David Gee as Chief Marketing Officer (CMO). Mr. Gee brings more than 25 years of global sales and marketing expertise and will serve as a member of Cellebrite’s executive leadership team, reporting directly to CEO Yossi Carmil. He will oversee Cellebrite’s global marketing strategy and execution to help the Company capitalize on the major growth opportunities ahead in the digital investigations marketplace.

Mr. Gee joins Cellebrite as digital crimes escalate exponentially, and criminal activities become more sophisticated, requiring law enforcement and enterprises to apply more advanced tools to fully capture, manage and analyze all the digital evidence at their disposal. Cellebrite’s end-to-end Case-to-Closure (C2C) platform helps investigative teams in both public and private sectors reach time-to-evidence quicker and close cases faster, smarter and more defensibly than ever before.

“Cellebrite stands on the precipice of an unparalleled opportunity. As we forge ahead, scaling our extraordinary growth, we welcome aboard David Gee, a strategic marketing luminary,” said Yossi Carmil, Cellebrite CEO. “His seasoned expertise will propel our global expansion. David embodies our vision and champions the ethical and responsible use of technology, recognizing its power to safeguard our world. Together, we’ll redefine what’s possible.”

As a seasoned industry veteran, Mr. Gee brings a wealth of experience to his role as CMO. His previous roles have left indelible marks, and now he’s ready to propel Cellebrite to new heights. Most recently, he served as CMO at Coherent Inc. where he digitally transformed the business and was part of the management team that doubled the market capitalization within two years. Previously, David was CMO at Imperva, Zuora and Infoblox and held senior marketing and operational roles at Hewlett Packard, Yahoo!, Sun Microsystems and IBM.

“It is rare to find an opportunity that fits my personal values, while also aligning with my skill set. I am thrilled to join Cellebrite and become part of such an important, mission-based business,” said Mr. Gee. “Cellebrite’s achievements to date are inspiring, and the opportunities ahead to further accelerate justice are exciting. I look forward to working with my new colleagues as we focus on executing the programs, campaigns, and initiatives that will broaden market awareness and adoption of the Company’s innovative digital investigative solutions.”

To learn more about Cellebrite and its Case-to-Closure Platform, please visit www.cellebrite.com.

About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Investigative platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on X at @Cellebrite.

References to Websites and Social Media Platforms
References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.

Caution Regarding Forward Looking Statements

This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include, but are not limited to, the following: helping our team further expand our business around the world; and executing the programs, campaigns and initiatives that will broaden market awareness of the Company’s innovative digital investigative solutions, fortify and expand our customer relationships globally, increase our market leadership and achieve our business objectives. Such forward-looking statements are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the purchase, acceptance and use of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; failure to manage its growth effectively; Cellebrite’s ability to introduce new solutions and add-ons; its dependency on its customers renewing their subscriptions; the low volume of business Cellebrite conducts via e-commerce; risks associated with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated with higher costs or unavailability of materials used to create its hardware product components; fluctuations in foreign currency exchange rates; lengthy sales cycle for some of Cellebrite’s solutions; near term declines in new or renewed agreements; risks associated with inability to retain qualified personnel and senior management; the security of Cellebrite’s operations and the integrity of its software solutions; risks associated with the negative publicity related to Cellebrite’s business and use of its products; risks related to Cellebrite’s intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with Cellebrite’s operations in Israel, including the ongoing Israel-Hamas war and the risk of a greater regional conflict; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations; risks associated with Cellebrite’s failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20-F filed with the SEC on March 21, 2024 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Media 

Victor Cooper
Sr. Director of Corporate Communications + Content Operations
Victor.cooper@cellebrite.com
+1 404.804.5910

Investor Relations 

Andrew Kramer
Vice President, Investor Relations
investors@cellebrite.com
+1 973.206.7760

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dd321307-8ce5-4237-86b7-324ddbd27380

GlobeNewswire Distribution ID 9078473

Zoom launches Zoom Workplace in AWS Marketplace

SAN JOSE, Calif., March 25, 2024 (GLOBE NEWSWIRE) — Today, Zoom announced that Zoom Workplace, Zoom’s AI-powered collaboration platform, is now available in AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services (AWS). Now customers can seamlessly purchase Zoom Workplace products –- such as Meetings, Team Chat, Phone, Whiteboard, Spaces — as well as Zoom Contact Center and Revenue Accelerator in AWS Marketplace.

Building on Zoom’s more than two years of success serving the Public Sector as an AWS independent software vendor (ISV), Zoom recognizes that it is crucial to equip customers with the right resources and opportunities to enhance their collaboration and communications in today’s digital-first world. This streamlined purchasing option of Zoom Workplace can help AWS customers consolidate their technology purchasing and billing of Zoom solutions, discover partners that can facilitate deployment, and maximize their usage of AWS committed resources.

“By making Zoom available through a private offer in AWS Marketplace, we are able to reach more customers and are better equipped to enable IT teams to consolidate their technology,” said Graeme Geddes, chief growth officer at Zoom. “At Zoom, we are excited to build upon our already strong relationship with AWS and work together further to help meet the business and technology needs of our customers.”

Zoom incorporates over 40 different AWS services, including compute, storage, and encryption capabilities. Zoom’s Customer Managed Key offering allows customers to bring their own encryption keys using AWS Key Management Service to help protect certain data. Additionally, AWS AppFabric integrates with the Zoom Developer Platform to help businesses break down data silos, improve cross-application workflows, enhance security observability, and support employee productivity. In 2023, AWS named Zoom as a NAMER finalist for its 2023 Geo and Global AWS Partner Award within the Education Partners of the Year category.

For Zoom channel partners that already participate in the Channel Partner Private Offer (CPPO) feature in AWS Marketplace, please reach out to your Zoom point of contact to express interest in working with Zoom on this in the future.

To access Zoom Workplace in AWS Marketplace, please visit this link.

Some features and products may not be available for all regions and industry verticals at launch.

About Zoom
Zoom’s mission is to provide one platform that delivers limitless human connection. Zoom Workplace — the company’s AI-powered, open collaboration platform built for modern work — will streamline communications, increase employee engagement, optimize in-person time, improve productivity, and offer customer choice with third-party apps and integrations. Zoom Workplace, powered by Zoom AI Companion, will include collaboration solutions like meetings, team chat, phone, scheduler, whiteboard, spaces, Workvivo, and more. Together with Zoom Workplace, Zoom’s Business Services for sales, marketing, and customer care teams, including Zoom Contact Center, strengthen customer relationships throughout the customer lifecycle. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

Zoom Public Relations
Bridget Moriarty
press@zoom.us

GlobeNewswire Distribution ID 9078508

Zoom and Avaya announce new strategic partnership to deliver enhanced collaboration experiences

Avaya selects Zoom‘s AI-powered collaboration platform, Zoom Workplace, to integrate with Avaya’s Communication and Collaboration Suite to help enterprises reimagine teamwork

SAN JOSE, Calif. and MORRISTOWN, N.J., March 25, 2024 (GLOBE NEWSWIRE) — Today, Zoom and Avaya announced a strategic partnership designed to deliver enhanced collaboration experiences to global enterprises. As part of the partnership, Avaya selected Zoom Workplace — Zoom’s AI-powered collaboration platform that will include meetings, team chat, scheduler, whiteboard, spaces, and more — to integrate with Avaya’s Communication & Collaboration Suite, providing customers with a new, streamlined way to manage their communications environments and workflows.

Additionally, Avaya will offer the integrated Zoom Workplace solution and will deliver an enhanced collaboration experience to its base, which boasts some of the industry’s largest enterprise customers.

Adding innovation value without disruption
Avaya customers can gain additional value from their existing investments in Avaya private cloud and premise-based solutions while also leveraging Zoom’s user experience and interface to power their collaboration needs.

“Today’s enterprises are seeking to benefit from the latest AI-powered innovations to help differentiate, accelerate, and grow, all while integrating new levels of performance with minimal disruption to existing core systems,” said Alan Masarek, Avaya CEO. “By partnering with Zoom, we can deliver on the promise of ‘innovation without disruption’ for Avaya customers, providing added value to enterprises through world-class collaboration experiences within the Avaya platform.”

“Zoom was built to offer a sophisticated yet easy-to-use product, and as Zoom has expanded to include hundreds more products and features, as well as generative AI integrated throughout, delivering an exceptional user experience is still core to who we are and something we continue to invest heavily in,” Eric S. Yuan, Zoom founder and CEO. “Customers and partners like Avaya continue to look to Zoom to power their collaboration needs because of its speed of innovation and because it just works. We are excited to deliver that same experience to the thousands of Avaya customers who will benefit from a simple yet powerful way to collaborate.”

Enhanced collaboration with Zoom and Avaya
Existing Avaya customers will retain their investments in Avaya’s solutions and devices while benefiting from Zoom’s AI-powered collaboration platform, Zoom Workplace.

Working together, Zoom and Avaya’s partnership is designed to deliver a joint solution that will provide an enhanced collaboration user experience for Avaya customers, including:

  • Interoperability between platforms and devices, enabling users to work in Zoom Workplace while also leveraging their existing investments in Avaya’s Communication & Collaboration Suite solutions — Avaya Aura and Avaya Enterprise Cloud — without disrupting investments in existing customizations, workflows, or infrastructure.
  • Access to Zoom AI Companion, Zoom’s generative AI digital assistant.
  • Collaboration solutions such as Zoom Team Chat, Zoom Scheduler, Zoom Whiteboard, flexible spaces, and more.

The new Avaya and integrated Zoom Workplace experience and device interoperability will be available to Avaya customers globally in the coming months. More details around the joint solution will be shared later this spring.

About Zoom

Zoom’s mission is to provide one platform that delivers limitless human connection. Zoom Workplace — the company’s AI-powered, open collaboration platform built for modern work — will streamline communications, increase employee engagement, optimize in-person time, improve productivity, and offer customer choice with third-party apps and integrations. Zoom Workplace, powered by Zoom AI Companion, will include collaboration solutions like meetings, team chat, phone, scheduler, whiteboard, spaces, Workvivo, and more. Together with Zoom Workplace, Zoom’s Business Services for sales, marketing, and customer care teams, including Zoom Contact Center, strengthen customer relationships across all stages of the customer lifecycle. Founded in 2011, Zoom is publicly traded (NASDAQ:ZM) and headquartered in San Jose, California. Get more info at zoom.com.

About Avaya
Businesses are built by the experiences they provide, and every day, millions of those experiences are delivered by Avaya. Organizations trust Avaya to provide innovative solutions for some of their most important ​ambitions and ​challenges,​ ​giving them the freedom to engage their customers and employees in ways that deliver the greatest business benefits. Avaya contact center and communications solutions power immersive, personalized, and unforgettable customer experiences that drive business momentum. With the freedom to choose their journey, there’s no limit to the experiences Avaya customers can create. Learn more at https://www.avaya.com.

Forward-Looking Statements
This press release contains express and implied “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits of Avaya using Zoom as its exclusive collaboration platform and product features and investments. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “project,” “will,” “would,” “should,” “could,” “can,” “predict,” “potential,” “target,” “explore,” “continue,” or the negative of these terms, and similar expressions intended to identify forward-looking statements. By their nature, these statements are subject to numerous uncertainties and risks, including factors beyond Zoom’s control, that could cause actual results, performance or achievement to differ materially and adversely from those anticipated or implied in the statements, including those described under the caption “Risk Factors” and elsewhere in Zoom’s most recent filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q for the fiscal quarter ended July 31, 2023. Forward-looking statements speak only as of the date the statements are made and are based on information available to Zoom at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. Zoom assumes no obligation to update forward-looking statements to reflect events or circumstances after the date they were made, except as required by law.

Zoom Public Relations
Candace Dean
press@zoom.us

Avaya Public Relations
Alex Alias
alalias@avaya.com

GlobeNewswire Distribution ID 9078503